Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis.
about
Analysis of PPARGC1B, RUNX3 and TBKBP1 polymorphisms in Chinese Han patients with ankylosing spondylitis: a case-control study.Whole Genome Expression Profiling and Signal Pathway Screening of MSCs in Ankylosing Spondylitis.Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy.Rebamipide prevents peripheral arthritis and intestinal inflammation by reciprocally regulating Th17/Treg cell imbalance in mice with curdlan-induced spondyloarthritis.Ankylosing spondylitis: from cells to genesWhole-Genome Expression Analysis and Signal Pathway Screening of Synovium-Derived Mesenchymal Stromal Cells in Rheumatoid Arthritis.Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis.Effects of Tripterygium glycosides on interleukin-17 and CD4(+)CD25(+)CD127(low) regulatory T-cell expression in the peripheral blood of patients with ankylosing spondylitis.Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells.T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis.Increased production of interleukin-17 over interleukin-10 by treg cells implicates inducible costimulator molecule in experimental spondyloarthritis.Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy.The Impact of Anti-TNF Therapy on CD4+ and CD8+ Cell Subsets in Ankylosing Spondylitis.Role of Stem Cells in Pathophysiology and Therapy of Spondyloarthropathies-New Therapeutic Possibilities?Hematopoietic and mesenchymal stem cells: a promising new therapy for spondyloarthritis?Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial.High frequency of circulating follicular helper T cells is correlated with B cell subtypes in patients with ankylosing spondylitis.
P2860
Q34700366-34357F7D-F037-48D1-A9C5-55F8BECAEBF6Q34721995-D9619981-DF2A-4096-B622-715337278858Q35239156-0EB1E18B-6760-4FB0-AF6E-903C1F354788Q37045417-475D4383-A2E6-46A9-90B6-DC7D8D2826EBQ37077734-26E46068-9184-438E-B358-0A88537C8EF3Q37239644-11C1084E-CAA4-4D29-92C3-77ACE4100FDCQ37454135-87AAE3E0-5FCF-491B-ACAD-6910D8304BBAQ40512588-0BD0158B-A778-46F2-9519-E51EA7698D77Q42211604-B56E132B-1738-4638-9CB3-D54DD66D7B7FQ43043328-77A3E24A-1DD1-4C26-B01A-B7E26C420291Q44466939-C4672A8E-EC7C-46A7-9EA2-675A0235ECECQ46941367-729030D8-ABD0-42E1-A6BA-536AA6DA4741Q47357132-7D58F2C1-7461-4F88-A94D-6FE0110C11DEQ48337725-3E8AEA63-2BB2-4396-9387-D1C0CD66DE71Q50025503-8523A46A-C6AD-4106-B278-89D2614DCA5FQ50957540-96FA6B47-F45B-409D-8DE2-33C97CB3D14DQ55054505-7CB732B6-A8D9-4E25-B4E9-A6D6D2E89D9D
P2860
Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Reduced immunomodulation poten ...... nce in ankylosing spondylitis.
@ast
Reduced immunomodulation poten ...... nce in ankylosing spondylitis.
@en
type
label
Reduced immunomodulation poten ...... nce in ankylosing spondylitis.
@ast
Reduced immunomodulation poten ...... nce in ankylosing spondylitis.
@en
prefLabel
Reduced immunomodulation poten ...... nce in ankylosing spondylitis.
@ast
Reduced immunomodulation poten ...... nce in ankylosing spondylitis.
@en
P2093
P2860
P356
P1476
Reduced immunomodulation poten ...... nce in ankylosing spondylitis.
@en
P2093
Huiyong Shen
Mingliang Ren
Xinjun Liang
Yanfeng Wu
P2860
P2888
P356
10.1186/AR3257
P577
2011-02-21T00:00:00Z
P5875
P6179
1020558686